Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isoindolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115894563A reveals a green HPA-catalyzed route for isoindolinones. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable supply solutions.
Patent CN113584507B reveals a green continuous flow electrochemical method for sulfonylated isoindolinone, offering metal-free production and scalable supply chain solutions.
Novel micro-reactor electrochemical method for trifluoromethylated isoindolinones. Green, scalable process reducing metal waste and costs for pharma supply chains.
Patent CN108948034B reveals a novel tandem reaction for high-purity isoindolinone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Green synthesis of isoindolinones using phenoxyacetonitrile. High yield, mild conditions. Cost-effective pharmaceutical intermediate manufacturing.
Patent CN112028816A reveals a novel route for bulky isoindoline derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability for complex heterocycles.
Patent CN109053543A reveals a base-catalyzed route for isoindole derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN107056677A details a room-temperature synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Novel AlCl3-catalyzed cyclization route for fungicide intermediates. Offers simplified purification and scalable production for agricultural chemical manufacturers.
Patent CN110343087B details a cobalt-catalyzed C-H activation method for isoindolinone derivatives, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Patent CN114507177B reveals a base-promoted synthesis route for isoindolinone intermediates using carbon dioxide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel MOF-Cu catalyzed Ugi reaction for high-purity dipeptide intermediates. Cost-effective, scalable synthesis with reusable catalyst for pharmaceutical applications.
Patent CN109232529A reveals mild Rh(III) catalysis for nitrogen heterocycles. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Patent CN102911109A reveals a scalable 4-step route for 6-amino-5-fluoro-1-isoindolinone, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN115057808A reveals a green Rh-catalyzed method for Z-isoindolinones. High stereoselectivity, no oxidants. Ideal for pharma intermediates supply.
Novel Ni-catalyzed route for sulfur-containing isoindolinones offers high yield and green oxidation for reliable pharmaceutical intermediate supply chains and cost reduction.
Patent CN110372774B reveals a novel MOF-Cu catalyzed Ugi reaction for isoindolinone dipeptides. Discover cost-effective agrochemical intermediate manufacturing solutions.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.